Joost S P Vermaat (J S P Vermaat)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 40

Top Topics

Epstein Barr Virus

Hodgkin Lymphoma

Lipopolysaccharide Induced

Top Venues

JCO oncology practice

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Mirian Brink, Francien Huisman, Frederik O Meeuwes, Marjolein W M van der Poel, Marie José Kersten, Mariëlle Wondergem, Lara Böhmer, F J S H Sherida Woei-A-Jin, Otto Visser, Rimke Oostvogels, Patty M Jansen, Arjan Diepstra, Tjeerd J F Snijders, Gerwin Huls, Joost S P Vermaat, Wouter J Plattel, Marcel Nijland
Treatment strategies and outcome in relapsed peripheral T-cell lymphoma: results from the Netherlands Cancer Registry. Blood advances 8 (14) (2024)
Patrick René Gerhard Eriksen, Fleur de Groot, Erik Clasen-Linde, Peter de Nully Brown, Ruben de Groen, Linea C Melchior, Andrea Daniela Maier, Marthe Minderman, Joost S P Vermaat, Christian von Buchwald, Steven T Pals, Steffen Heegaard
Sinonasal DLBCL: molecular profiling identifies subtypes with distinctive prognosis and targetable genetic features. Blood advances 8 (8) (2024)
Mirian Brink, Francien Huisman, Frederik Okko Meeuwes, Marjolein W M van der Poel, Marie José Kersten, Marielle J Wondergem, Lara H Bohmer, F J S H Sherida Woei-A-Jin, Otto J Visser, Rimke Oostvogels, Patty M Jansen, Arjan Diepstra, Tjeerd J F Snijders, Gerwin A Huls, Joost S P Vermaat, Wouter J Plattel, Marcel Nijland
Treatment strategies and outcome in relapsed peripheral T-cell lymphoma: results from the Netherlands Cancer Registry. Blood advances (2024)
Peter A von dem Borne, Berit M Kemps-Mols, Liesbeth C de Wreede, Adriaan A van Beek, Tjeerd J F Snijders, Daniëlle van Lammeren, Janneke Tijmensen, Aniko Sijs-Szabó, Mirjam A Oudshoorn, Constantijn J M Halkes, Peter van Balen, W A Erik Marijt, Jennifer M L Tjon, Joost S P Vermaat, Hendrik Veelken
The degree of HLA matching determines the incidence of cytokine release syndrome and associated nonrelapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide. Leukemia & lymphoma (2024)
Peter A von dem Borne, Berit M Kemps-Mols, Liesbeth C de Wreede, Adriaan A van Beek, Tjeerd J F Snijders, Daniëlle van Lammeren, Janneke Tijmensen, Aniko Sijs-Szabó, Mirjam A Oudshoorn, Constantijn J M Halkes, Peter van Balen, W A Erik Marijt, Jennifer M L Tjon, Joost S P Vermaat, Hendrik Veelken
The degree of HLA matching determines the incidence of cytokine release syndrome and associated nonrelapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide. Leukemia & lymphoma 65 (9) (2024)
Janneke A Eken, Marvyn T Koning, Kristyna Kupcova, Julieta Haydee Sepúlveda Yáñez, Ruben A L de Groen, Edwin Quinten, Jurriaan Janssen, Cornelis A M van Bergen, Joost S P Vermaat, Arjen H G Cleven, Marcelo A Navarrete, Bauke Ylstra, Daphne de Jong, Ondrej Havranek, Hassan Jumaa, Joan Hendrik Veelken
Antigen-independent, autonomous B cell receptor signaling drives activated B cell DLBCL. The Journal of experimental medicine 221 (5) (2024)
Patrick René Gerhard Eriksen, Fleur de Groot, Erik Clasen-Linde, Peter de Nully Brown, Ruben de Groen, Linea C Melchior, Andrea Daniela Maier, Marthe Minderman, Joost S P Vermaat, Christian von Buchwald, Steven T Pals, Steffen Heegaard
Sinonasal DLBCL: molecular profiling identifies subtypes with distinctive prognosis and targetable genetic features. Blood advances 8 (8) (2024)
Stine Dahl Vest, Patrick René Gerhard Eriksen, Fleur A de Groot, Ruben A L de Groen, Anne H R Kleij, Marina Knudsen Kirkegaard, Peter Kamper, Peter Kristian Rasmussen, Christian von Buchwald, Peter de Nully Brown, Jens Folke Kiilgaard, Joost S P Vermaat, Steffen Heegaard
The Genetic Profile of Large B-Cell Lymphomas Presenting in the Ocular Adnexa. International journal of molecular sciences 25 (6) (2024)
Janneke A Eken, Marvyn T Koning, Kristyna Kupcova, Julieta Haydee Sepúlveda Yáñez, Ruben A L de Groen, Edwin Quinten, Jurriaan Janssen, Cornelis A M van Bergen, Joost S P Vermaat, Arjen H G Cleven, Marcelo A Navarrete, Bauke Ylstra, Daphne de Jong, Ondrej Havranek, Hassan Jumaa, Joan Hendrik Veelken
Antigen-independent, autonomous B cell receptor signaling drives activated B cell DLBCL. The Journal of experimental medicine 221 (5) (2024)
Peter A von dem Borne, Berit M Kemps-Mols, Liesbeth C de Wreede, Adriaan A van Beek, Tjeerd J F Snijders, Daniëlle van Lammeren, Janneke Tijmensen, Aniko Sijs-Szabó, Mirjam A Oudshoorn, Constantijn J M Halkes, Peter van Balen, W A Erik Marijt, Jennifer M L Tjon, Joost S P Vermaat, Hendrik Veelken
The degree of HLA matching determines the incidence of cytokine release syndrome and associated nonrelapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide. Leukemia & lymphoma 65 (9) (2024)
Patrick René Gerhard Eriksen, Fleur de Groot, Erik Clasen-Linde, Peter de Nully Brown, Ruben de Groen, Linea C Melchior, Andrea Daniela Maier, Marthe Minderman, Joost S P Vermaat, Christian von Buchwald, Steven T Pals, Steffen Heegaard
Sinonasal DLBCL: molecular profiling identifies subtypes with distinctive prognosis and targetable genetic features. Blood advances 8 (8) (2024)
Mirian Brink, Francien Huisman, Frederik O Meeuwes, Marjolein W M van der Poel, Marie José Kersten, Mariëlle Wondergem, Lara Böhmer, F J S H Sherida Woei-A-Jin, Otto Visser, Rimke Oostvogels, Patty M Jansen, Arjan Diepstra, Tjeerd J F Snijders, Gerwin Huls, Joost S P Vermaat, Wouter J Plattel, Marcel Nijland
Treatment strategies and outcome in relapsed peripheral T-cell lymphoma: results from the Netherlands Cancer Registry. Blood advances 8 (14) (2024)
Patrick René Gerhard Eriksen, Fleur A de Groot, Erik Clasen-Linde, Peter de Nully Brown, Ruben Al de Groen, Linea Melchior, Andrea Daniela Maier, Marthe Minderman, Joost S P Vermaat, Christian von Buchwald, Steven T Pals, Steffen Heegaard
Sinonasal DLBCL: molecular profiling identifies subtypes with distinctive prognoses and targetable genetic features. Blood advances (2024)
Janneke A Eken, Marvyn T Koning, Kristyna Kupcova, Julieta Haydee Sepúlveda Yáñez, Ruben A L de Groen, Edwin Quinten, Jurriaan Janssen, Cornelis A M van Bergen, Joost S P Vermaat, Arjen H G Cleven, Marcelo A Navarrete, Bauke Ylstra, Daphne de Jong, Ondrej Havranek, Hassan Jumaa, Joan Hendrik Veelken
Antigen-independent, autonomous B cell receptor signaling drives activated B cell DLBCL. The Journal of experimental medicine 221 (5) (2024)
Stine Dahl Vest, Patrick René Gerhard Eriksen, Fleur A de Groot, Ruben A L de Groen, Anne H R Kleij, Marina Knudsen Kirkegaard, Peter Kamper, Peter Kristian Rasmussen, Christian von Buchwald, Peter de Nully Brown, Jens Folke Kiilgaard, Joost S P Vermaat, Steffen Heegaard
The Genetic Profile of Large B-Cell Lymphomas Presenting in the Ocular Adnexa. International journal of molecular sciences 25 (6) (2024)
Stine Dahl Vest, Patrick René Gerhard Eriksen, Fleur A de Groot, Ruben A L de Groen, Anne H R Kleij, Marina Knudsen Kirkegaard, Peter Kamper, Peter Kristian Rasmussen, Christian von Buchwald, Peter de Nully Brown, Jens Folke Kiilgaard, Joost S P Vermaat, Steffen Heegaard
The Genetic Profile of Large B-Cell Lymphomas Presenting in the Ocular Adnexa. International journal of molecular sciences 25 (6) (2024)
Mirian Brink, Francien Huisman, Frederik O Meeuwes, Marjolein W M van der Poel, Marie José Kersten, Mariëlle Wondergem, Lara Böhmer, F J S H Sherida Woei-A-Jin, Otto Visser, Rimke Oostvogels, Patty M Jansen, Arjan Diepstra, Tjeerd J F Snijders, Gerwin Huls, Joost S P Vermaat, Wouter J Plattel, Marcel Nijland
Treatment strategies and outcome in relapsed peripheral T-cell lymphoma: results from the Netherlands Cancer Registry. Blood advances 8 (14) (2024)
Janneke A Eken, Marvyn T Koning, Kristyna Kupcova, Julieta Haydee Sepúlveda Yáñez, Ruben A L de Groen, Edwin Quinten, Jurriaan Janssen, Cornelis A M van Bergen, Joost S P Vermaat, Arjen H G Cleven, Marcelo A Navarrete, Bauke Ylstra, Daphne de Jong, Ondrej Havranek, Hassan Jumaa, Joan Hendrik Veelken
Antigen-independent, autonomous B cell receptor signaling drives activated B cell DLBCL. The Journal of experimental medicine 221 (5) (2024)
A Vera de Jonge, Erik D van Werkhoven, Avinash G Dinmohamed, Marcel Nijland, Aeilko H Zwinderman, Patrick M Bossuyt, Martine S Veldhuis, Emma G G M Rutten, Rogier Mous, Joost S P Vermaat, Yorick Sandberg, Eva de Jongh, Yavuz M Bilgin, Rinske Boersma, Harry Koene, Marie José Kersten, Daphne de Jong, Martine E D Chamuleau
A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients. Blood cancer journal 13 (1) (2023)
Diede A G van Bladel, Wendy B C Stevens, Leonie I Kroeze, Ruben Al de Groen, Fleur A de Groot, Jessica Lm van der Last-Kempkes, Madeleine R Berendsen, Jos Rijntjes, Jeroen A C W Luijks, Irina Bonzheim, Ellen van der Spek, Wouter J Plattel, Johannes Pruijt, Susan Dpwm de Jonge-Peeters, Gerjo A Velders, Chantal Lensen, Esther R van Bladel, Birgit Federmann, Brigiet Hoevenaars, Agata Pastorczak, Jutte van der Werff Ten Bosch, Joost S P Vermaat, Peet Nooijen, Konnie M Hebeda, Falko Fend, Arjan Diepstra, J Han Jm van Krieken, Patricia J T A Groenen, Michiel van den Brand, Blanca Scheijen
A significant proportion of classic Hodgkin lymphoma recurrences represents clonally unrelated second primary lymphoma. Blood advances (2023)
Johanna A A Bult, Francien Huisman, Yujie Zhong, Nick Veltmaat, Joost Kluiver, Sanne H Tonino, Joost S P Vermaat, Martine E D Chamuleau, Arjan Diepstra, Anke van den Berg, Wouter J Plattel, Mirian Brink, Marcel Nijland
A population-based study of transformed marginal zone lymphoma: identifying outcome-related characteristics. Blood cancer journal 13 (1) (2023)
Diana Al-Sarayfi, M Brink, M E D Chamuleau, R Brouwer, R S van Rijn, D Issa, W Deenik, G Huls, R Mous, Joost S P Vermaat, A Diepstra, J M Zijlstra, T van Meerten, M Nijland
R-miniCHOP versus R-CHOP in elderly patients with diffuse large B-cell lymphoma: A propensity matched population-based study. American journal of hematology (2023)
Janneke W de Boer, Elise R A Pennings, Ankie Kleinjan, Jaap A van Doesum, Anne M Spanjaart, Pim G N J Mutsaers, Margot Jak, Marjolein W M van der Poel, Maria T Kuipers, Judit A Adam, Arjan Diepstra, Lianne Koens, Suzanne van Dorp, Joost S P Vermaat, Anne G H Niezink, Marie José Kersten, Tom van Meerten
Inflammatory reactions mimic residual or recurrent lymphoma on [18F]FDG-PET/CT after CD19-directed CAR T-cell therapy. Blood advances (2023)
Aldo A Acosta-Medina, Paul Geraeds Kemps, Timo Ce Zondag, Jithma P Abeykoon, Jelske Forma-Borst, Eline Christine Steenwijk, Elizabeth Arnoldina Maria Feijen, Jop C Teepen, N Nora Bennani, Susan M Schram, Mithun Vinod Shah, Caroline Davidge-Pitts, Matthew J Koster, Jay H Ryu, Robert Vassallo, William Oliver Tobin, Jason R Young, Surendra Dasari, Karen L Rech, Aishwarya Ravindran, Arjen Hg Cleven, Robert M Verdijk, Carel J M van Noesel, Brian V Balgobind, Gerrit J Bouma, Peerooz Saeed, Jos A M Bramer, Ruben Al de Groen, Joost S P Vermaat, Michiel Adreanus van de Sande, Egbert F Smit, Anton W Langerak, J Tom van Wezel, Sanne H Tonino, Cor van den Bos, Jan A M van Laar, Ronald S Go, Gaurav Goyal, Astrid G S van Halteren
BRAF V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis. Blood (2023)
Janneke W de Boer, Kylie Keijzer, Elise R A Pennings, Jaap A van Doesum, Anne M Spanjaart, Margot Jak, Pim G N J Mutsaers, Suzanne van Dorp, Joost S P Vermaat, Marjolein W M van der Poel, Lisanne V van Dijk, Marie José Kersten, Anne G H Niezink, Tom van Meerten, null null
Population-Based External Validation of the EASIX Scores to Predict CAR T-Cell-Related Toxicities. Cancers 15 (22) (2023)
Anne M Spanjaart, Elise R A Pennings, Pim G N J Mutsaers, Suzanne van Dorp, Margot Jak, Jaap A van Doesum, Janneke W de Boer, Anne G H Niezink, Milan Kos, Joost S P Vermaat, Aniko Sijs-Szabo, Marjolein W M van der Poel, Inger S Nijhof, Maria T Kuipers, Martine E D Chamuleau, Pieternella J Lugtenburg, Jeanette K Doorduijn, Yasmina I M Serroukh, Monique C Minnema, Tom van Meerten, Marie José Kersten, null null
The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands. Cancers 15 (17) (2023)
Mirian Brink, Frederik O Meeuwes, Marjolein W M van der Poel, Marie José Kersten, Mariëlle Wondergem, Pim G N J Mutsaers, Lara H Böhmer, F J S H Sherida Woei-A-Jin, Otto Visser, Rimke Oostvogels, Patty M Jansen, Wouter J Plattel, Gerwin A Huls, Joost S P Vermaat, Marcel Nijland
Impact of etoposide and ASCT on survival among patients aged <65 years with stage II to IV PTCL: a population-based cohort study. Blood 140 (9) (2022)
Anne M Spanjaart, Elise R A Pennings, Milan Kos, Pim G N J Mutsaers, Pieternella J Lugtenburg, Tom van Meerten, Jaap A van Doesum, Monique C Minnema, Margot Jak, Suzanne van Dorp, Joost S P Vermaat, Marjolein W M van der Poel, Martijn G H van Oijen, Maria T Kuipers, Inger S Nijhof, Marie José Kersten
Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities. JCO oncology practice 19 (3) (2022)
Josée J M Zijlstra-Baalbergen, George Follows, René-Olivier Casasnovas, Joost S P Vermaat, Nagesh Kalakonda, Sylvain Choquet, Brian Hill, Catherine Thieblemont, Federica Cavallo, Fatima De la Cruz, John Kuruvilla, Nada Hamad, Ulrich Jaeger, Paolo Caimi, Ronit Gurion, Krzysztof Warzocha, Sameer Bakhshi, Juan-Manuel Sancho, Michael Schuster, Miklos Egyed, Fritz Offner, Theodoros P Vassilakopoulos, Priyanka Samal, Matthew Ku, Jenny Xu, Kelly Corona, Kamal Chamoun, Jatin Shah, Miguel Canales, Marie Maerevoet
The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study. Cancers 14 (3) (2022)
Anne M Spanjaart, Elise R A Pennings, Milan Kos, Pim G N J Mutsaers, Pieternella J Lugtenburg, Tom van Meerten, Jaap A van Doesum, Monique C Minnema, Margot Jak, Suzanne van Dorp, Joost S P Vermaat, Marjolein W M van der Poel, Martijn G H van Oijen, Maria T Kuipers, Inger S Nijhof, Marie José Kersten
Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities. JCO oncology practice 19 (3) (2022)
Anne M Spanjaart, Elise R A Pennings, Milan Kos, Pim G N J Mutsaers, Pieternella J Lugtenburg, Tom van Meerten, Jaap A van Doesum, Monique C Minnema, Margot Jak, Suzanne van Dorp, Joost S P Vermaat, Marjolein W M van der Poel, Martijn G H van Oijen, Maria T Kuipers, Inger S Nijhof, Marie José Kersten
Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities. JCO oncology practice 19 (3) (2022)
Fleur A de Groot, Ruben A L de Groen, Anke van den Berg, Patty M Jansen, King H Lam, Pim G N J Mutsaers, Carel J M van Noesel, Martine E D Chamuleau, Wendy B C Stevens, Jessica Rodrigues Plaça, Rogier Mous, Marie José Kersten, Marjolein M W van der Poel, Thomas A Tousseyn, F J S H Sherida Woei-A-Jin, Arjan Diepstra, Marcel Nijland, Joost S P Vermaat
Biological and Clinical Implications of Gene-Expression Profiling in Diffuse Large B-Cell Lymphoma: A Proposal for a Targeted BLYM-777 Consortium Panel as Part of a Multilayered Analytical Approach. Cancers 14 (8) (2022)
Anne M Spanjaart, Elise R A Pennings, Milan Kos, Pim G N J Mutsaers, Pieternella J Lugtenburg, Tom van Meerten, Jaap A van Doesum, Monique C Minnema, Margot Jak, Suzanne van Dorp, Joost S P Vermaat, Marjolein W M van der Poel, Martijn G H van Oijen, Maria T Kuipers, Inger S Nijhof, Marie José Kersten
Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities. JCO oncology practice (2022)
Anne M R Schrader, Ruben A L de Groen, Rein Willemze, Patty M Jansen, Koen D Quint, Arjen H G Cleven, J Tom van Wezel, Ronald van Eijk, Dina Ruano, J H Hendrik Veelken, Cornelis P Tensen, Karen J Neelis, Laurien A Daniels, Esther Hauben, F J S H Sherida Woei-A-Jin, A M Annemie Busschots, Maarten H Vermeer, Joost S P Vermaat
Genetic Stability of Driver Alterations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type and Their Relapses: A Rationale for the Use of Molecular-Based Methods for More Effective Disease Monitoring. Cancers 14 (20) (2022)
Anne M Spanjaart, Elise R A Pennings, Milan Kos, Pim G N J Mutsaers, Pieternella J Lugtenburg, Tom van Meerten, Jaap A van Doesum, Monique C Minnema, Margot Jak, Suzanne van Dorp, Joost S P Vermaat, Marjolein W M van der Poel, Martijn G H van Oijen, Maria T Kuipers, Inger S Nijhof, Marie José Kersten
Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities. JCO oncology practice 19 (3) (2022)
Anne M Spanjaart, Elise R A Pennings, Milan Kos, Pim G N J Mutsaers, Pieternella J Lugtenburg, Tom van Meerten, Jaap A van Doesum, Monique C Minnema, Margot Jak, Suzanne van Dorp, Joost S P Vermaat, Marjolein W M van der Poel, Martijn G H van Oijen, Maria T Kuipers, Inger S Nijhof, Marie José Kersten
Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities. JCO oncology practice 19 (3) (2022)
Johanna A A Bult, Jessica R Plaça, Erlin A Haacke, M Martijn Terpstra, Gwenny M Verstappen, Frederik K L Spijkervet, Frans G M Kroese, Wouter J Plattel, Joost S P Vermaat, Hendrika Bootsma, Bert Van der Vegt, Arjan Diepstra, Anke van den Berg, Klaas Kok, Marcel Nijland
Low Mutational Burden of Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue in Patients with Primary Sjogren's Syndrome. Cancers 14 (4) (2022)
Anne M Spanjaart, Elise R A Pennings, Milan Kos, Pim G N J Mutsaers, Pieternella J Lugtenburg, Tom van Meerten, Jaap A van Doesum, Monique C Minnema, Margot Jak, Suzanne van Dorp, Joost S P Vermaat, Marjolein W M van der Poel, Martijn G H van Oijen, Maria T Kuipers, Inger S Nijhof, Marie José Kersten
Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities. JCO oncology practice 19 (3) (2022)
Fleur A de Groot, Lorraine M de Haan, Ruben A L de Groen, Linda Heijmen, Tom van Wezel, Ronald van Eijk, Lara Bohmer, Freek Bot, Rosita L Ten Berge, Arjan Diepstra, Hendrik Veelken, Arjen H G Cleven, Patty M Jansen, Joost S P Vermaat
Synchronous diffuse large B-cell lymphoma and mantle cell lymphoma: support for low-threshold biopsies and genetic testing. Leukemia & lymphoma 63 (5) (2021)
Ruben A L de Groen, Ronald van Eijk, Stefan Böhringer, J Tom van Wezel, Richard Raghoo, Dina Ruano, Patty M Jansen, Inge H Briaire-de Bruijn, Fleur A de Groot, Karin Kleiverda, Liane Te Boome, Valeska Terpstra, Henriette Levenga, Alina Nicolae, Eduardus F M Posthuma, Isabelle Focke-Snieders, Lizan Hardi, Wietske C E den Hartog, Lara H Bohmer, Pancras C W Hogendoorn, Anke van den Berg, Arjan Diepstra, Marcel Nijland, Pieternella J Lugtenburg, Marie José Kersten, Steven T Pals, Joan Hendrik Veelken, Judith V M G Bovée, Arjen H G Cleven, Joost S P Vermaat
Frequent mutated B2M, EZH2, IRF8, and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype. Blood advances 5 (19) (2021)